Valuation: EMV Capital plc

Market Cap 14.82M 19.73M 17.35M 16.12M 27.8M 1.91B 28.3M 193M 75.17M 932M 74.05M 72.45M 3.23B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.79M 18.36M 16.14M 15M 25.87M 1.78B 26.33M 179M 69.95M 867M 68.91M 67.42M 3.01B EV / Sales 2026 *
4.02x
EV / Sales 2027 * 4.01x
Free-Float
52.46%
Yield 2026 *
-
Yield 2027 * -
1 day-1.89%
1 week-1.89%
Current month+0.97%
1 month+0.97%
3 months+10.64%
6 months-7.96%
Current year-8.77%
1 week 52
Extreme 52
55
1 month 51
Extreme 51
55
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 2020-04-30
Director of Finance/CFO 45 2025-11-30
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 2019-10-13
Director/Board Member 47 2022-12-08
Chairman 61 2023-01-31
Date Insider Type Main position Quantity % Market Cap.
1/8/26 Sell 7,000 0.0250%
1/8/26 Buy 7,000 0.0250%
12/19/25 Sell

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
-1.89%-1.89%+5.05%-7.14% 19.73M
+1.60%+2.52%+58.50%+14.80% 3.37B
-1.82%-4.46%-19.71%-4.34% 2.88B
+1.00%+1.41%+52.29%+26.88% 2.02B
+3.53%+3.23%+73.71%+117.30% 1.25B
0.00%0.00%-1.72%-7.02% 717M
+6.79%+2.48%+115.18%+175.43% 521M
0.00%0.00%-4.67%-8.33% 397M
0.00%0.00%-44.44%-75.18% 384M
0.00%0.00%-2.71%-12.24% 373M
Average +1.24%-0.30%+23.15%+22.02% 1.19B
Weighted average by Cap. +1.64%-1.03%+31.59%+24.11%

Financials

2026 *2027 *
Net sales 3.43M 4.56M 4.01M 3.73M 6.43M 442M 6.55M 44.59M 17.39M 216M 17.13M 16.76M 748M 3.75M 4.99M 4.39M 4.08M 7.04M 484M 7.16M 48.79M 19.03M 236M 18.75M 18.34M 818M
Net income - -
Net Debt -1.03M -1.37M -1.2M -1.12M -1.93M -133M -1.96M -13.38M -5.22M -64.67M -5.14M -5.03M -224M 233K 310K 272K 253K 437K 30M 444K 3.03M 1.18M 14.63M 1.16M 1.14M 50.76M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., CetroMed Limited, NetScientific America, Inc., EMV Director Services Limited, EMV Capital Technology Limited, and ProAxsis Limited, among others.
Employees
21
Date Price Change Volume
26-07-24 GBX 52.00 -1.89% 7,311
26-07-23 GBX 53.00 0.00% 57,971
26-07-22 GBX 53.00 0.00% 214
26-07-21 GBX 53.00 0.00% 11,404
26-07-20 GBX 53.00 0.00% 32,197
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5300GBP
Average target price
1.320GBP
Spread / Average Target
+149.06%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock